title: [Agranulocytosis induced by captopril after 4 months of treatment].
abstract: A case of a patient treated by captopril who developed agranulocytosis and sepsis from pulmonary origin is presented. Shortly, we reviewed the pathogenesis of this complication and highlight the fact that in this patient this adverse reaction to captopril was late.
authors.affiliation: Servicio de Medicina Interna, Hospital Provincial Santa María Madre, Orense.
authors.forename: J
authors.initials: J
authors.lastname: Fernández Seara
authors.forename: L M
authors.initials: LM
authors.lastname: Domínguez Alvarez
authors.forename: R
authors.initials: R
authors.lastname: Rodríguez Pérez
authors.forename: J A
authors.initials: JA
authors.lastname: Pereira Jorge
authors.forename: A
authors.initials: A
authors.lastname: Rodríguez Canal
mesh_terms: D000380:Agranulocytosis / Q000139:chemically induced*; D002216:Captopril / Q000009:adverse effects*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D004198:Disease Susceptibility; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000209:etiology; D011552:Pseudomonas Infections / Q000209:etiology
chemical_list: D002216:Captopril
vernacular_title: Agranulocitosis inducida por captopril tras cuatro meses de tratamiento.